Prophylactic immunisation against traveller's diarrhoea caused by enterotoxin-forming strains of Escherichia coli and against cholera: does it make sense and for whom?

Travel Med Infect Dis. 2008 Nov;6(6):362-7. doi: 10.1016/j.tmaid.2006.05.003.

Abstract

Traveller's diarrhoea (TD) constitutes the most common disease relevant to travel medicine with ETEC as the leading causative pathogen. Cholera is the most serious, but very rare form of TD. ETEC and cholera share pathogenic mechanisms by producing a toxin that has an 80% amino acid homology. A consensus of German-speaking experts sees the indication to use the whole cell/B subunit oral cholera vaccine (WC--BS) if cholera is a risk for aid workers or travellers with an anticipated threat of cholera who stay under poor hygienic conditions. The use of the vaccine should be considered in the indication to avoid ETEC TD for travellers with predisposing illness or medication or for travellers at risk to develop a serious course.

MeSH terms

  • Bacterial Vaccines / administration & dosage*
  • Cholera / complications
  • Cholera / epidemiology
  • Cholera / prevention & control*
  • Cholera / therapy
  • Dysentery / etiology
  • Dysentery / prevention & control*
  • Enterotoxins / metabolism*
  • Escherichia coli / physiology
  • Escherichia coli Infections / complications
  • Escherichia coli Infections / epidemiology
  • Escherichia coli Infections / prevention & control*
  • Escherichia coli Infections / therapy
  • Health Planning Guidelines
  • Humans
  • Immunization*
  • Travel*
  • Vibrio cholerae / physiology

Substances

  • Bacterial Vaccines
  • Enterotoxins